ZEB2 and breast carcinoma: Meanwhile, mesenchymal markers and epithelial markers were decreased and increased, respectively, when LncRNA‐ZEB2‐AS1 knocked down, suggesting that knocking down lncRNA‐ZEB2‐AS1 results in the inhibition of the EMT of breast cancer (Figure 4C,D).